1. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An overview. Journal of nutritional science 2016, 5, e47.
2. Kao, T.H.,Wu,W.M., Hung, C.F.,Wu,W.B., Chen, B.H. Anti-inflammatory effects of isoflavone powder produced from soybean cake. Journal of Agricultural and Food Chemistry 2007, 55, 11068–11079
3. 張偉斌, 紀., 潘美連, 宋晏仁, 廖幼婕, 楊建昌, 劉德明. 異位性皮膚炎門診藥費支出分析 drug expense of atopic dermatitis in taiwan 北市醫學雜誌 2013, 10, 229-243.
4. Gandhi, N.A.; Pirozzi, G.; Graham, N.M.H. Commonality of the il-4/il-13 pathway in atopic diseases. Expert review of clinical immunology 2017, 13, 425-437.
5. Seif, F.; Khoshmirsafa, M.; Aazami, H.; Mohsenzadegan, M.; Sedighi, G.; Bahar, M. The role of jak-stat signaling pathway and its regulators in the fate of t helper cells. Cell communication and signaling : CCS 2017, 15, 23.
6. Ulzii D, Kido-Nakahara M, Nakahara T, et al. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes. Int J Mol Sci. 2019;20(13):3324.
7. Wilson SR, Thé L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–295
8. Chiu, T.M., Huang, C.C., Lin, T.J., Fang, J.Y., Wu, N.L., Hung, C.F. In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. J. Ethnopharmacol. 2009, 126 (1), 108–113.
9. Li, H.J., Wu, N.L., Lee, G.A., Hung, C.F. The therapeutic potential and molecular mechanism of isoflavone extract against psoriasis. Sci. Rep. 2018, 8 (1), 6335.
10. Erwin, E.A.; James, H.R.; Gutekunst, H.M.; Russo, J.M.; Kelleher, K.J.; Platts-Mills, T.A. Serum ige measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010, 104, 496-502.
27
11. Mitchell, E.B.; Crow, J.; Chapman, M.D.; Jouhal, S.S.; Pope, F.M.; Platts-Mills, T.A. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet (London, England) 1982, 1, 127-130.
12. Wang, L.F.; Lin, J.Y.; Hsieh, K.H.; Lin, R.H. Epicutaneous exposure of protein antigen induces a predominant th2-like response with high ige production in mice. Journal of immunology (Baltimore, Md. : 1950) 1996, 156, 4077-4082.
13. Zaniboni, M.C.; Samorano, L.P.; Orfali, R.L.; Aoki, V. Skin barrier in atopic dermatitis: Beyond filaggrin. Anais brasileiros de dermatologia 2016, 91, 472-478.
14. Boguniewicz, M.; Leung, D.Y. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunological reviews 2011, 242, 233-246.
15. Cabanillas, B.; Novak, N. Atopic dermatitis and filaggrin. Current opinion in immunology 2016, 42, 1-8.
16. Liang, Y.; Chang, C.; Lu, Q. The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms. Clinical reviews in allergy & immunology 2016, 51, 315-328.
17. Furue, M.; Chiba, T.; Tsuji, G.; Ulzii, D.; Kido-Nakahara, M.; Nakahara, T.; Kadono, T. Atopic dermatitis: Immune deviation, barrier dysfunction, ige autoreactivity and new therapies. Allergology international : official journal of the Japanese Society of Allergology 2017, 66, 398-403.
18. Matsunaga, M.C.; Yamauchi, P.S. Il-4 and il-13 inhibition in atopic dermatitis. Journal of drugs in dermatology : JDD 2016, 15, 925-929.
19. Zamorano, J.; Wang, H.Y.; Wang, L.M.; Pierce, J.H.; Keegan, A.D. Il-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.
Journal of immunology (Baltimore, Md. : 1950) 1996, 157, 4926-4934.
20. Yanagida, M.; Fukamachi, H.; Ohgami, K.; Kuwaki, T.; Ishii, H.; Uzumaki, H.; Amano, K.; Tokiwa, T.; Mitsui, H.; Saito, H., et al. Effects of t-helper 2-type cytokines, interleukin-3 (il-3), il-4, il-5, and il-6 on the survival of cultured human mast cells. Blood 1995, 86, 3705-3714.
21. Lutz, M.B.; Schnare, M.; Menges, M.; Rossner, S.; Rollinghoff, M.; Schuler, G.; Gessner, A.
Differential functions of il-4 receptor types i and ii for dendritic cell maturation and il-12 production
28
and their dependency on gm-csf. Journal of immunology (Baltimore, Md. : 1950) 2002, 169, 3574-3580.
22. Herberth, G.; Heinrich, J.; Roder, S.; Figl, A.; Weiss, M.; Diez, U.; Borte, M.; Herbarth, O.;
Lehmann, I. Reduced ifn-gamma- and enhanced il-4-producing cd4+ cord blood t cells are
associated with a higher risk for atopic dermatitis during the first 2 yr of life. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2010, 21, 5-13.
23. Hershey, G.K.; Friedrich, M.F.; Esswein, L.A.; Thomas, M.L.; Chatila, T.A. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. The New England journal of medicine 1997, 337, 1720-1725.
24. Gour, N.; Wills-Karp, M. Il-4 and il-13 signaling in allergic airway disease. Cytokine 2015, 75, 68-78.
25. Rael, E.L.; Lockey, R.F. Interleukin-13 signaling and its role in asthma. The World Allergy Organization journal 2011, 4, 54-64.
26. Hamid, Q.; Naseer, T.; Minshall, E.M.; Song, Y.L.; Boguniewicz, M.; Leung, D.Y. In vivo expression of il-12 and il-13 in atopic dermatitis. The Journal of allergy and clinical immunology 1996, 98, 225-231.
27. David, M.; Ford, D.; Bertoglio, J.; Maizel, A.L.; Pierre, J. Induction of the il-13 receptor alpha2-chain by il-4 and il-13 in human keratinocytes: Involvement of stat6, erk and p38 mapk pathways.
Oncogene 2001, 20, 6660-6668.
28. Esche, C.; de Benedetto, A.; Beck, L.A. Keratinocytes in atopic dermatitis: Inflammatory signals.
Current allergy and asthma reports 2004, 4, 276-284.
29. David, M.; Bertoglio, J.; Pierre, J. Tnf-alpha potentiates il-4/il-13-induced il-13ralpha2 expression.
Annals of the New York Academy of Sciences 2002, 973, 207-209.
30. Hartman, G.L.; West, E.D.; Herman, T.K. Crops that feed the world 2. Soybean—worldwide production, use, and constraints caused by pathogens and pests. Food Security 2011, 3, 5-17.
29
31. Sean O’Keefe, L.B., Jyotsna Sharman. Soybean nutrition. SM Journal of Nutrition and Metabolism 2015, 1, 1006.
32. Michel Mozeika Araújo, G.B.F.a.A.L.C.a.H.V. Soybean and isoflavones – from farm to fork.
Soybean - Bio-Active Compounds, Hany A. El-Shemy, IntechOpen 2013.
33. Nikolić, I.L.; Savić-Gajić, I.M.; Tačić, A.D.; Savić, I.M.J.A.t. Classification and biological activity of phytoestrogens: A review. 2017, 6, 96-106.
34. Sakai, T.; Kogiso, M.J.T.j.o.m.i. Soy isoflavones and immunity. 2008, 55, 167-173.
35. Zhang, H.-Y.; Cui, J.; Zhang, Y.; Wang, Z.-L.; Chong, T.; Wang, Z.-M.J.C.m.j. Isoflavones and prostate cancer: A review of some critical issues. 2016, 129, 341.
36. Coon, J.T.; Pittler, M.H.; Ernst, E.J.P. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: A systematic review and meta-analysis. 2007, 14, 153-159.
37. Swami, S.; Krishnan, A.V.; Moreno, J.; Bhattacharyya, R.B.; Peehl, D.M.; Feldman, D.J.T.J.o.n.
Calcitriol and genistein actions to inhibit the prostaglandin pathway: Potential combination therapy to treat prostate cancer. 2007, 137, 205S-210S.
38. Yamaguchi, M.J.Y.Z. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. 2006, 126, 1117-1137.
39. Messina, M.; McCaskill-Stevens, W.; Lampe, J.W.J.J.o.t.N.C.I. Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings. 2006, 98, 1275-1284.
40. Sirotkin, A.V.; Harrath, A.H.J.E.j.o.p. Phytoestrogens and their effects. 2014, 741, 230-236.
41. Ming, L.G.; Chen, K.M.; Xian, C.J.J.J.o.c.p. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. 2013, 228, 513-521.
42. Kładna, A.; Berczyński, P.; Kruk, I.; Piechowska, T.; Aboul‐Enein, H.Y.J.L. Studies on the antioxidant properties of some phytoestrogens. 2016, 31, 1201-1206.
43. Johnson GL and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912